150
Views
6
CrossRef citations to date
0
Altmetric
Drug Evaluations

A new paradigm for managing dyslipidemia with combination therapy: laropiprant + niacin + simvastatin

, MBBS, , PhD FRCP & , MD PhD
Pages 437-449 | Published online: 08 Feb 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

James M. Backes, Robert J. Padley & Patrick M. Moriarty. (2011) Important Considerations for Treatment with Dietary Supplement versus Prescription Niacin Products. Postgraduate Medicine 123:2, pages 70-83.
Read now
Dick C Chan & Gerald F Watts. (2011) Dyslipidaemia in the metabolic syndrome and type 2 diabetes: pathogenesis, priorities, pharmacotherapies. Expert Opinion on Pharmacotherapy 12:1, pages 13-30.
Read now

Articles from other publishers (4)

Zhiguo Wang & Baofeng YangZhiguo Wang & Baofeng Yang. 2022. Polypharmacology. Polypharmacology 133 198 .
Anca D. Petrescu, Huan Huang, Gregory G. Martin, Avery L. McIntosh, Stephen M. Storey, Danilo Landrock, Ann B. Kier & Friedhelm Schroeder. (2013) Impact of L-FABP and glucose on polyunsaturated fatty acid induction of PPARα-regulated β-oxidative enzymes. American Journal of Physiology-Gastrointestinal and Liver Physiology 304:3, pages G241-G256.
Crossref
Won-Jeong KimHyun-Chang KoByung-Soo KimMoon-Bum Kim. (2012) Successful Treatment of Xanthoma Disseminatum with Combined Lipid Lowering Agents. Annals of Dermatology 24:3, pages 380.
Crossref
Helen Vosper. (2011) Extended Release Niacin-Laropiprant in Patients with Hypercholesterolemia or Mixed Dyslipidemias Improves Clinical Parameters. Clinical Medicine Insights: Cardiology 5, pages CMC.S7601.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.